Raffaele Giusti

6.4k total citations · 1 hit paper
65 papers, 1.2k citations indexed

About

Raffaele Giusti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Raffaele Giusti has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Raffaele Giusti's work include Lung Cancer Treatments and Mutations (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Lung Cancer Research Studies (12 papers). Raffaele Giusti is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Lung Cancer Research Studies (12 papers). Raffaele Giusti collaborates with scholars based in Italy, United States and United Kingdom. Raffaele Giusti's co-authors include Carla Ripamonti, Federica Aielli, Manohar Sharma, Roman Rolke, Marie Fallon, Peter Hoskin, Paolo Marchetti, Ilaria Grazia Zizzari, Andrea Botticelli and Marianna Nuti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Raffaele Giusti

58 papers receiving 1.2k citations

Hit Papers

Management of cancer pain in adult patients: ESMO Clinica... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele Giusti Italy 13 450 381 293 243 225 65 1.2k
Kunihiko Ishitani Japan 16 444 1.0× 183 0.5× 102 0.3× 140 0.6× 306 1.4× 48 1.1k
Constance L. Monitto United States 17 110 0.2× 231 0.6× 123 0.4× 438 1.8× 438 1.9× 36 1.3k
Fade Mahmoud United States 20 701 1.6× 41 0.1× 193 0.7× 118 0.5× 403 1.8× 51 1.5k
Deborah Panebianco United States 22 235 0.5× 89 0.2× 45 0.2× 124 0.5× 233 1.0× 64 1.4k
Dolores B. Njoku United States 19 171 0.4× 181 0.5× 79 0.3× 37 0.2× 208 0.9× 51 1.5k
I. Robieux Canada 18 246 0.5× 73 0.2× 112 0.4× 256 1.1× 127 0.6× 27 776
Jinyi Li China 17 162 0.4× 82 0.2× 304 1.0× 52 0.2× 222 1.0× 73 1.2k
Haibo Zhang China 17 247 0.5× 56 0.1× 235 0.8× 32 0.1× 171 0.8× 63 1.1k
Myoung Hwa Kim South Korea 20 154 0.3× 245 0.6× 179 0.6× 32 0.1× 266 1.2× 51 1.1k
Donald B. Wender United States 14 568 1.3× 35 0.1× 173 0.6× 55 0.2× 295 1.3× 31 1.1k

Countries citing papers authored by Raffaele Giusti

Since Specialization
Citations

This map shows the geographic impact of Raffaele Giusti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Giusti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Giusti more than expected).

Fields of papers citing papers by Raffaele Giusti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Giusti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Giusti. The network helps show where Raffaele Giusti may publish in the future.

Co-authorship network of co-authors of Raffaele Giusti

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Giusti. A scholar is included among the top collaborators of Raffaele Giusti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Giusti. Raffaele Giusti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Guerrera, Francesco, Filippo Tommaso Gallina, Eleonora Balzani, et al.. (2025). Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials. Lung Cancer. 209. 108760–108760. 1 indexed citations
3.
Siciliano, Maria Anna, Maria D’Apolito, Francesco Grillone, et al.. (2025). Do age and performance status matter? A systematic review and network meta-analysis of immunotherapy studies in untreated advanced/metastatic non-oncogene addicted NSCLC. Frontiers in Immunology. 16. 1635056–1635056.
4.
Moro, Maria Luisa, et al.. (2024). Management of overlapping immune-related myocarditis, myositis, and myasthenia in a young patient with advanced NSCLC: a case report. Frontiers in Oncology. 14. 1431971–1431971. 6 indexed citations
5.
Giusti, Raffaele, et al.. (2024). Prospective assessment of targeted symptom management on supportive care in cancer: An observational cohort study.. Journal of Clinical Oncology. 42(16_suppl). e24073–e24073.
6.
7.
Giusti, Raffaele, Marco Filetti, Pasquale Lombardi, et al.. (2023). 2087P Impact of cancer pain on quality of life and financial well-being: A cross-sectional study on symptom management. Annals of Oncology. 34. S1097–S1097. 1 indexed citations
8.
Marinelli, Daniele, et al.. (2023). Palliative sedation and time to death in home palliative care: retrospective analysis. BMJ Supportive & Palliative Care. 13(e3). e890–e893. 1 indexed citations
9.
Molassiotis, Alex, Mary Lou Affronti, Mapi Fleury, et al.. (2023). 2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies. Supportive Care in Cancer. 32(1). 30–30. 6 indexed citations
10.
Filetti, Marco, Pasquale Lombardi, Raffaele Giusti, et al.. (2023). Efficacy and safety of antiemetic regimens for highly emetogenic chemotherapy-induced nausea and vomiting: A systematic review and network meta-analysis. Cancer Treatment Reviews. 115. 102512–102512. 11 indexed citations
11.
Filetti, Marco, et al.. (2021). Profilazione genomica completa nel carcinoma polmonare neuroendocrino a grandi cellule: i tempi stanno cambiando. Recenti Progressi in Medicina. 112(1). 1e–4e. 1 indexed citations
12.
Giorgio, Roberto De, F Zucco, Giuseppe Chiarioni, et al.. (2021). Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Advances in Therapy. 38(7). 3589–3621. 32 indexed citations
13.
Filetti, Marco, Dario Trapani, Alessio Cortellini, et al.. (2021). Knowledge and attitudes of Italian medical oncologists and palliative care physicians toward medical use of cannabis in cancer care: a national survey. Supportive Care in Cancer. 29(12). 7845–7854. 8 indexed citations
14.
Botticelli, Andrea, Silvia Mezi, Giulia Pomati, et al.. (2020). Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1. Frontiers in Immunology. 11. 1243–1243. 34 indexed citations
15.
Roth, Patrick, Andrea Pace, Émilie Le Rhun, et al.. (2020). Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up. Annals of Oncology. 32(2). 171–182. 39 indexed citations
16.
Filetti, Marco, et al.. (2020). 79P Statins and immunotherapy: Togetherness makes strength - the potential effect of statins on immunotherapy for NSCLC. Annals of Oncology. 31. S1449–S1449. 1 indexed citations
17.
Roberto, Michela, Andrea Botticelli, Fabiana Letizia Cecere, et al.. (2019). L’immunoterapia nel tumore del polmone non a piccole cellule: ritorno al futuro. Recenti Progressi in Medicina. 110(12). 587–593. 1 indexed citations
18.
19.
Giusti, Raffaele, Daniela Iacono, Ida Paris, Luigi Ruco, & Paolo Marchetti. (2012). Multidisciplinary approach to fetal adenocarcinoma of the lung: A case report. Thoracic Cancer. 5(1). 97–100. 1 indexed citations
20.
Galante, Domenico, et al.. (1988). Efficacy and safety of ciprofloxacin in the treatment of UTIs and RTIs in patients affected by liver diseases. Infection. 16(S1). S57–S61. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026